266 results on '"Althaus, Karina"'
Search Results
2. Hypofibrinolysis in pediatric patients with veno-occlusive disease in hematopoietic stem cell transplantation
3. Heparin-activated procoagulant platelet assay: a flow cytometry-based functional test for heparin-induced thrombocytopenia
4. Uterine allograft removal by total laparoscopic hysterectomy after successful cesarean delivery in a living-donor uterus recipient with uterovaginal agenesis (MRKHS)
5. Uncoupling of platelet granule release and integrin activation suggests GPIIb/IIIa as a therapeutic target in COVID-19
6. COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants
7. The interaction between anti-PF4 antibodies and anticoagulants in vaccine-induced thrombotic thrombocytopenia
8. Antibody‐mediated procoagulant platelet formation in COVID‐19 is AKT dependent
9. Upregulation of cAMP prevents antibody-mediated thrombus formation in COVID-19
10. Multicentre evaluation of 5B9, a monoclonal anti‐PF4/heparin IgG mimicking human HIT antibodies, as an internal quality control in HIT functional assays: Communication from the ISTH SSC Subcommittee on Platelet Immunology
11. Antibody-induced procoagulant platelets in severe COVID-19 infection
12. Characteristics Associated with COVID-19 Breakthrough Infections after Booster Vaccinations in Healthcare Workers: Insights from the TüSeRe:exact Study.
13. Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
14. Organ Donation From a Brain Dead Donor With Vaccine-induced Immune Thrombotic Thrombocytopenia After Ad26.COV2.S: The Risk of Organ Microthrombi
15. Heparin-activated procoagulant platelet assay: a flow cytometry based functional test for heparin induced thrombocytopenia
16. An international external quality assessment for laboratory diagnosis of heparin‐induced thrombocytopenia
17. Inhibition of GPIb-α-mediated apoptosis signaling enables cold storage of platelets
18. Correlation between Clinical Characteristics and Antibody Levels in COVID-19 Convalescent Plasma Donor Candidates
19. Platelet phosphatidylserine is the critical mediator of thrombosis in heparin-induced thrombocytopenia
20. Diagnostic Performance of a Particle Gel Immunoassay in Vaccine-Induced Immune Thrombotic Thrombocytopenia
21. Low-dose alemtuzumab induction in a tailored immunosuppression protocol for sensitized kidney transplant recipients
22. Membrane oxygenator longevity was higher in Argatroban treated patients undergoing vvECMO
23. Vaccine Side Effects in Health Care Workers after Vaccination against SARS-CoV-2: Data from TüSeRe:exact Study
24. Characterization of Shear Stress Mediated Platelet Dysfunction: Data from an Ex Vivo Model for Extracorporeal Circulation and a Prospective Clinical Study
25. Hypofibrinolysis in Pediatric Patients with Veno-Occlusive Disease in Hematopoietic Stem Cell Transplantation
26. Platelet Phosphatidylserine Is the Critical Mediator of Increased Thrombus Formation in Heparin-Induced Thrombocytopenia
27. Uterine allograft removal by total laparoscopic hysterectomy after successful cesarean delivery in a living-donor uterus recipient with uterovaginal agenesis (MRKHS)
28. Vaccine side effects in health care workers after vaccination against SARS-CoV-2: data from TüSeRe:exact study
29. Investigations to Assess the Impact of Syk-Inhibition on Antibody-Mediated Desialylation: Novel Implications on Therapy for Immune Thrombocytopenia
30. Cytometry, Immunofluorescence Microscopy, and Light Transmission Aggregometry in the Diagnosis of Platelet Functional Disorders
31. Platelets and Sera from Donors of Convalescent Plasma after Mild COVID-19 Show No Procoagulant Phenotype
32. Living kidney donor evaluation is associated with early identification of life‐changing diagnoses in potentially healthy donor candidates
33. Platelet phosphatidylserine is the critical mediator of thrombosis in heparin-induced thrombocytopenia
34. Uncoupling of platelet granule release and integrin activation suggests GPIIb/IIIa as therapeutic target in COVID-19
35. Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants
36. Characterization of Shear Stress Mediated Platelet Dysfunction: Data from an Ex Vivo Model for Extracorporeal Circulation and a Prospective Clinical Study.
37. Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants.
38. Assessment and Monitoring of Coagulation in Patients with COVID-19: A Review of Current Literature
39. Diagnosis of Platelet Function Disorders: A Challenge for Laboratories
40. Evaluation of automated immunoassays in the diagnosis of heparin induced thrombocytopenia
41. Vaccine Side Effects in Health Care Workers after Vaccination against SARS-CoV-2: Data from TüSeRe:exact Study.
42. Living kidney donor evaluation is associated with early identification of life‐changing diagnoses in potentially healthy donor candidates.
43. Antibody binding and ACE2 binding inhibition is significantly reduced for the Omicron variant compared to all other variants of concern
44. Combined use of the high heparin step and optical density to optimize diagnostic sensitivity and specificity of an anti-PF4/heparin enzyme-immunoassay
45. No Correlation between Anti-PF4 and Anti–SARS-CoV-2 Antibodies after ChAdOx1 nCoV-19 Vaccination
46. COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants
47. The SSC platelet immunology register of VITT and VIITP: Toward standardization of laboratory and clinical parameters
48. Flucloxacillin-induced immune thrombocytopenia
49. Antibody‐mediated platelet activation in COVID‐19: A coincidence or a new mechanism of the dysregulated coagulation system?
50. PF4-Dependent Immunoassays in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: Results of an Interlaboratory Comparison
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.